Showing results (221-230 of 253) with videos related to

Sort By:
Pageof 26
Proceedings. Biological Sciences|August 30, 2023
COVID-19 vaccine coverage targets to inform reopening plans in a low incidence settingEamon Conway, Camelia R Walker, Christopher Baker, et al.
Infection and Immunity|December 11, 2019
Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge ModelKirstie M Mangas, Andrew H Buultjens, Jessica L Porter, et al.
Trials|December 7, 2023
A blueprint for a multi-disease, multi-domain Bayesian adaptive platform trial incorporating adult and paediatric subgroups: the Staphylococcus aureus Network Adaptive Platform trialRobert K Mahar, Anna McGlothlin, Michael Dymock, et al.
Development (Cambridge, England)|January 5, 2007
Controlled overexpression of Pax6 in vivo negatively autoregulates the Pax6 locus, causing cell-autonomous defects of late cortical progenitor proliferation with little effect on cortical arealizationMartine Manuel, Petrina A Georgala, Catherine B Carr, et al.
BMC Family Practice|September 16, 2021
Attitudes towards chiropractic: a repeated cross-sectional survey of Canadian family physiciansJason W Busse, Sushmitha Pallapothu, Brian Vinh, et al.
Communicable Diseases Intelligence (2018)|July 18, 2024
Opportunities to strengthen respiratory virus surveillance systems in Australia: lessons learned from the COVID-19 responseFreya M Shearer, Laura Edwards, Martyn Kirk, et al.
Nature Communications|April 24, 2024
Overlapping Streptococcus pyogenes and Streptococcus dysgalactiae subspecies equisimilis household transmission and mobile genetic element exchangeOuli Xie, Cameron Zachreson, Gerry Tonkin-Hill, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2025
Within-host modeling of primaquine-induced hemolysis in hemizygote glucose-6-phosphate dehydrogenase deficient healthy volunteersJames A Watson, Parinaz Mehdipour, Robert Moss, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2022
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis BJosef Wagner, Lilly Yuen, Margaret Littlejohn, et al.
Ebiomedicine|December 11, 2022
HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapyJennifer M Zerbato, Anchalee Avihingsanon, Kasha P Singh, et al.
Pageof 26